Navigation Links
Reportlinker Adds The Clinical Trials Business
Date:12/14/2010

p>

CYTOKINETICS 107

TABLE 55 CLINICAL PIPELINE AS OF 12/31/2009 108

DENDREON 108

TABLE 56 CLINICAL PIPELINE AS OF 12/31/2009 109

DYNAVAX TECHNOLOGIES 110

TABLE 57 CLINICAL PIPELINE AS OF 12/31/2009 110

ELAN 110

TABLE 58 CLINICAL PIPELINE AS OF 12/31/2009 111

ENZON PHARMACEUTICALS 111

TABLE 59 CLINICAL PIPELINE AS OF 12/31/2009 112

EPICEPT CORPORATION 112

TABLE 60 CLINICAL PIPELINE AS OF 12/31/2009 113

GENENTECH 113

TABLE 61 CLINICAL PIPELINE AS OF 12/31/2009 114

TABLE 61 (CONTINUED) 115

GENZYME 116

TABLE 62 CLINICAL PIPELINE AS OF 12/31/2009 117

GILEAD 117

TABLE 63 CLINICAL PIPELINE AS OF 12/31/2009 118

GTC BIOTHERAPEUTICS, INC. 119

TABLE 64 CLINICAL PIPELINE AS OF 12/31/2009 119

GTX 120

TABLE 65 CLINICAL PIPELINE AS OF 12/31/2009 120

HUMAN GENOME SCIENCES 120

TABLE 66 CLINICAL PIPELINE AS OF 12/31/2009 121

IDERA PHARMACEUTICALS, INC. 121

TABLE 67 CLINICAL PIPELINE AS OF 12/31/2009 122

IMMUNOGEN, INC. 122

TABLE 68 CLINICAL PIPELINE AS OF 12/31/2009 123

IMMUNOMEDICS, INC. 123

TABLE 69 CLINICAL PIPELINE AS OF 12/31/2009 124

LORUS THERAPEUTICS INC. 124

TABLE 70 CLINICAL PIPELINE AS OF 12/31/2009 124

MAXYGEN 125

TABLE 71 CLINICAL PIPELINE AS OF 12/31/2009 125

MYRIAD PHARMACEUTICALS, INC. 125

TABLE 72 CLINICAL PIPELINE AS OF 12/31/2009 126

NOVO NORDISK A/S 126

TABLE 73 CLINICAL PIPELINE AS OF 12/31/2009 127

NPS PHARMACEUTICALS, INC. 127

TABLE 74 CLINICAL PIPELINE AS OF 12/31/2009 128

REPLIGEN CORPORATION 128

TABLE 75 CLINICAL PIPELINE AS OF 12/31/2009 129

SANGAMO BIOSCIENCES, INC. 129

TABLE 76 CLINICAL PIPELINE AS OF 12/31/2009 129

SEATTLE GENETICS, I
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Reportlinker Adds Pharmaceutical Key Trends 2010
2. Reportlinker Adds Antiemetics: Technologies and Global Markets
3. Reportlinker Adds Anti-Counterfeiting Packaging Technologies in the Global Pharmaceutical and Food Industries
4. Reportlinker Adds European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2011
5. Reportlinker Adds U.S. Market for Patient Monitoring Devices 2011
6. Reportlinker Adds European Markets for Video, High-Tech and Integrated OT Equipment 2011
7. Reportlinker Adds Corporate Strategies in Consumer Health 2010
8. Reportlinker Adds Allergic Conjunctivitis - Pipeline Assessment and Market Forecasts to 2017
9. Reportlinker Adds Chinese Markets for Drug Delivery System
10. Reportlinker Adds Prostate Cancer - Italy Drug Forecasts and Treatment Analysis to 2020
11. Reportlinker Adds Asia-Pacific Endoscopy Devices Market Outlook to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" ... specialty products, announced today that Dr. Robert Grieve ... Jason Napolitano , executive vice president and ... MicroCap Conference, which is being held May 30, 2013 in ... Hyatt Hotel. The Company,s presentation is scheduled ...
(Date:5/24/2013)... May 24, 2013 China Biologic Products, Inc. ... fully integrated plasma-based biopharmaceutical company in China ... learned from a public announcement issued by Shanghai RAAS ... listed on Shenzhen Stock Exchange, that on May 21, ... ("Ms. Chan"), one of the shareholders of the Company, ...
(Date:5/24/2013)... May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... participate in the Deutsche Bank Health Care Conference to ... Hotel.  Mr. Adrian Adams , Chief ... overview of the Company and its product pipeline at ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4
... Campath May Lead to Overall Survival in Patients with Poor ... FRANCISCO, Dec. 9 Bayer HealthCare Pharmaceuticals Inc. today announced ... showed activity in high-risk chronic lymphocytic leukemia (CLL) patients who ... 50th Annual Meeting of the American Society of Hematology in ...
... 8 Millennium: The Takeda Oncology Company today ... of patients from the large, international Phase III ... with previously untreated multiple myeloma given VELCADE, melphalan ... efficacy in all patient sub-groups, including those with ...
Cached Medicine Technology:Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 2Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 3Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 4Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 5Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 6Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 7Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 8Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 9Three Studies Presented at the American Society of Hematology Annual Meeting Showed Response to Treatment with Campath(R) in Patients with High-Risk CLL 10Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 2Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 3Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 4Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 5Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma 6
(Date:5/24/2013)... 2013 National Geographic questioned in an article ... of remembrance is getting lost in the swirl of summer ... and prompted some research and analysis on the subject based ... A statistical evaluation of around 180 ecards shared by Americans, ... the emotions of fun and celebration. In the modern ...
(Date:5/24/2013)... Lake City, UT (PRWEB) May 24, 2013 ... MonaVie Latin America, as a new member of the Ethics ... “I am proud to have been elected to this council ... ethical basis of the direct selling industry,” says Patrocinio. , ... a positive contributor to Brazil’s economy. The direct selling industry ...
(Date:5/24/2013)... This report “EpiCast Report: Meningococcal Disease ... the risk factors and global trends for meningococcal disease ... Spain, UK, Australia, and Brazil). It includes a 10-year ... by age (<1, 1–4, 5–14, 15–24, 25–44, 45–64, and ... in these markets. The other serogroups, namely serogroups A ...
(Date:5/24/2013)... According to the new market research report “Micro ... 2016)” published by MarketsandMarkets, global micro irrigation system market ... of year 2010 and is expected to reach $3,414.7 ... from 2011 to 2016. , Browse:, , ... Figures , 370 pages and in-depth Table ...
(Date:5/24/2013)... Just about any bodyweight training program includes a variety of ... Dallas, GA that uses a variety of bodyweight conditioning circuits ... used enough. , “The medicine ball pushup is ... By keeping your hands on a medicine ball, the core ... much harder than a standard pushup. This unique bodyweight chest ...
Breaking Medicine News(10 mins):Health News:Is Memorial Day More Than A Three-Day Weekend 2Health News:MonaVie Brazil Executive Elected to Ethics Board of ABEVD 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 2Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 3Health News:Meningococcal Disease Market Analysis and 2022 Forecasts in New Research Report at RnRMarketResearch.com 4Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 2Health News:Micro Irrigation System Market to Reach $3414.7 Million by 2016 at a CAGR of 17.9% - New Report by MarketsandMarkets 3Health News:Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com 2
... Million Americans Have Parkinson,s Disease, Roughly ... ... 21 Accolade, a Texas-based home,healthcare and hospice provider, observes ... Parkinson,s disease.,Accolade,s innovative short-term program enables people living with the,disease ...
... proved more beneficial than individual grief counseling, study finds ... experience the unexpected death of a parent after a ... finding that has major implications for helping children deal ... "Often children who have lost a parent are given ...
... than 6 millimeters in diameter appear more likely to ... in the April issue of Archives of Dermatology, one ... diameter guidelines currently used by dermatologists to screen for ... method to screen for melanoma, according to background information ...
... Decisions on Bottom Line Return at 3rd Annual ... Pharmaceutical Market Research Summit, NEW ... the pharmaceutical analytics company Eularis, will be,delivering a presentation on ... Research and Decisions on Bottom Line Return., ...
... of West Nile Virus and Other Diseases, SACRAMENTO, ... in hand. Coinciding with the launch of mosquito season, ... to April 25,2008 West Nile Virus and Mosquito and ... a mosquito-borne disease that can result in,debilitating cases of ...
... suggests , , MONDAY, April 21 (HealthDay News) -- The ... disease than women appear during the adolescent years, according a ... , "This is not what we would have predicted," said ... the University of Minnesota Children,s Hospital, and lead author of ...
Cached Medicine News:Health News:April is National Parkinson's Disease Awareness Month 2Health News:April is National Parkinson's Disease Awareness Month 3Health News:Treating PTSD Helps Kids Deal With Loss 2Health News:Larger skin lesions appear more likely to be melanomas 2Health News:Eularis to Address Making the Right Research Decision for ROI 2Health News:State Legislature Declares April 21 to 25, 2008 West Nile Virus and Mosquito and Vector Control Awareness Week 2Health News:Heart Disease Risks Hit Boys in Teens 2
Super High Density, multi-frequency, phased array burr hole transducer. Excellent for taking biopsy samples and shunt placements....
Super High Density, multi-frequency, convex array transducer for scanning during craniotomies. Same footprint as the UST-987-7.5 but with stronger penetration for deep cavernous tumors and other deep...
High resolution, multi-frequency, HST version of the UST-987-7.5. Provides even greater image detail, better resolution, and penetration....
... The 5548 is our High Penetration ... frequencies ranging from 3 to 8 MHz. ... transducer, offering Pure Harmonic Detection with 4 ... superficial or deeper vessels. The high color ...
Medicine Products: